A reduced supply of blood to the brain is widely regarded as a primary contributor to numerous forms of dementia, including Alzheimer’s disease. Recently, scientists pinpointed a novel regulatory mechanism governing this blood delivery, which may also shed light on how it becomes compromised. The findings from this study are detailed in the journal PNAS.
Researchers at the University of Vermont determined that a specific fat molecule helps maintain equilibrium within this system. In preclinical trials involving mice afflicted with Alzheimer’s, disrupting this equilibrium led to observable complications.
Correcting this imbalance successfully reinstated a more typical pattern of blood flow, thereby opening up new avenues for comprehending and addressing the cerebral alterations associated with dementia.
“This discovery represents a significant advancement in our ongoing efforts to prevent dementia and neurovascular ailments,” commented pharmacologist Osama Harraz.
Building upon prior research focused on endothelial cells—the cells lining the interior walls of blood vessels—the investigative team directed their attention to the Piezo1 protein, which functions as a pressure sensor within these cells. Should this sensor become overly stimulated, cerebral blood flow can be negatively impacted.
By analyzing the brain activity in the test mice, the researchers ascertained that the lipid molecule PIP2 operates as a braking mechanism for Piezo1. When brain cells are active, PIP2 levels naturally drop, activating Piezo1 to boost blood flow precisely where it is needed.
In mouse models of Alzheimer’s disease, researchers observed an abnormally low concentration of PIP2. This deficiency resulted in the over-activation of Piezo1, directing excessive blood flow to areas where it wasn’t required, thus disrupting overall circulation.
Crucially, when the research team restored PIP2 levels in these afflicted mice, the metrics for cerebral blood flow largely returned to normal parameters.
It is perhaps too early to claim a complete understanding of this mechanism—this was a preliminary investigation conducted exclusively in murine subjects—but it establishes another promising pathway for exploring the root causes of dementia.
Vascular dementia, where impaired brain blood supply is a central issue, stands as one of the most prevalent dementia types, affecting millions globally. Blood flow problems are also believed to play a role in Alzheimer’s pathology, although the damaging accumulation of toxic proteins is likely a more dominant factor there.
Given that blood flow dictates the delivery of both oxygen and nutrients to the brain, the implications extend beyond dementia itself. Maintaining this precise balance is essential for the brain’s proper functionality.
“These outcomes pave the way for a therapeutic methodology aimed at enhancing cerebral perfusion in conditions where Piezo1 activity is altered, and the implications might reach beyond merely regulating blood flow in the brain,” the researchers noted in their published paper.
While our grasp of dementia steadily improves, significant unknowns persist regarding how these disorders initiate and why some individuals exhibit greater susceptibility than others. Even in the context of vascular dementia, the specific variables that influence localized blood flow remain unclear.
Investigations such as this contribute to filling these knowledge gaps by identifying the molecular players involved.
The team’s subsequent plan involves scrutinizing the precise nature of the interaction between PIP2 and Piezo1. Understanding this molecular interplay will be vital for gaining control over this system and potentially restoring both healthy circulation and, perhaps, cognitive abilities.
“We are unveiling the intricate systems behind these debilitating illnesses, and we can now commence contemplating how to utilize this biological intelligence to devise treatment options,” Harraz concluded.
About the Author
